• Olaparib (AZD2281): Precision Tools for DNA Damage Response

  2026-06-18

  Olaparib (AZD2281) has transformed DNA damage response and BRCA-associated cancer research by enabling researchers to dissect homologous recombination deficiency, tumor radiosensitization, and localized drug delivery strategies. This article delivers actionable protocols, troubleshooting insights, and advanced use-cases, highlighting how APExBIO’s Olaparib supports high-fidelity, reproducible cancer research workflows.

• Levofloxacin: Applied Workflows for Antibacterial and Bone R

  2026-06-18

  Levofloxacin, a synthetic fluoroquinolone antibiotic, empowers researchers to dissect bacterial DNA replication while providing a unique window into osteoblast and chondrocyte biology. This guide distills evidence-backed protocols, troubleshooting tips, and advanced applications to maximize the value of Levofloxacin from APExBIO in both antibacterial and bone metabolism assays.

• PXR Activation Drives Liver Regeneration and CYP Induction i

  2026-06-17

  This study demonstrates that activating the pregnane X receptor (PXR) in rats induces liver regeneration and hepatomegaly while simultaneously upregulating the metabolic activity and protein expression of key cytochrome P450 enzymes, CYP3A1/2 and CYP2C6/11. These findings illuminate the coordinated role of PXR signaling in hepatic growth and enhanced detoxification, providing valuable insights for drug metabolism research and liver disease modeling.

• Aztreonam in Multidrug-Resistant Gram-Negative Research: Pre

  2026-06-17

  Explore how Aztreonam, a monocyclic β-lactam antibiotic, empowers advanced research on Gram-negative resistance and drug metabolism. This article delivers an in-depth, practical analysis for scientists seeking to optimize assay design against the evolving backdrop of multidrug resistance.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-06-16

  Chen et al. (2025) provide a comprehensive molecular and epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. Their findings reveal extensive plasmid- and chromosome-mediated carriage of blaNDM-1, high multidrug resistance, and efficient gene transfer, shaping future research on resistance surveillance and intervention.

• Aztreonam: Monocyclic β-Lactam Antibiotic Workflows & Insigh

  2026-06-16

  Aztreonam’s unique monocyclic β-lactam structure delivers targeted, reproducible inhibition of Gram-negative aerobic bacteria and modulates bone marrow and hepatic enzyme responses. This article presents optimized workflows, troubleshooting strategies, and translational tips for leveraging APExBIO's Aztreonam in advanced resistance and metabolism research.

• Cell Counting Kit-8: Next-Gen Cell Viability for Translation

  2026-06-15

  Explore how the Cell Counting Kit-8 (CCK-8) empowers translational researchers to bridge in vitro findings and clinical breakthroughs. This article blends state-of-the-art mechanistic insight with practical strategic guidance, contextualized by recent advances in bioprinted liver models and evolving regulatory landscapes. Discover how CCK-8’s sensitivity and workflow simplicity accelerate robust, reproducible results across high-content cell proliferation, viability, and cytotoxicity assays, and why its adoption is integral for next-generation disease modeling.

• Cefodizime in Translational Infectious Disease Research

  2026-06-15

  This article examines Cefodizime, a third-generation cephalosporin antibiotic, as a powerful translational research tool. By integrating mechanistic insight and strategic protocol guidance, we illustrate how Cefodizime’s unique pharmacology advances antimicrobial research—particularly for respiratory and urinary tract infection models—while also addressing immunomodulatory effects, resistance modeling, and workflow optimization.

• Polyether Ionophore Toxicity: Mechanisms and Research Implic

  2026-06-14

  The reviewed study systematically examines the clinical and molecular mechanisms of polyether ionophore toxicity, focusing on their effects on ion regulation in animal models. By elucidating structural classes, ion transport modes, and toxicity pathways, the paper lays a foundation for both safer veterinary use and the rational design of ionophore-based therapeutics, including anti-cancer agents.

• Faropenem Sodium: Protocol Innovations for Anaerobic Infecti

  2026-06-13

  Faropenem sodium stands out as a penem antibiotic with unmatched efficacy against anaerobic and resistant bacterial strains. This guide translates its unique pharmacokinetic and broad-spectrum properties into actionable protocols and troubleshooting strategies for advanced antimicrobial research workflows.

• Levofloxacin: Mechanism, Benchmarks, and Research Integratio

  2026-06-12

  Levofloxacin is a synthetic fluoroquinolone antibiotic that inhibits bacterial DNA gyrase, blocking DNA replication. Its reproducible effects in osteoblast inhibition and cartilage metabolism make it a key tool in antibacterial and tissue research. APExBIO’s Levofloxacin (B1959) provides validated performance metrics for both microbiological and cell-based assays.

• Aztreonam in Advanced Resistance Modeling: Metabolism, Bone

  2026-06-12

  Explore the multifaceted roles of Aztreonam, a monocyclic β-lactam antibiotic, in cutting-edge resistance modeling. This article reveals new insights into metabolic, hematopoietic, and genetic factors, offering a distinct perspective for scientific research.

• Sulfachloropyridazine: Workflow Reliability in Microbial Res

  2026-06-11

  This article addresses persistent laboratory challenges in cell viability and microbial susceptibility assays, highlighting how Sulfachloropyridazine (SKU BA1082) from APExBIO delivers reliable, reproducible results. By exploring practical Q&A scenarios, it guides scientists through experimental optimization, data interpretation, and product selection in the context of enzyme inhibition, microbial ecology, and in vivo infection models.

• Methicillin Sodium Salt: Precision Tools for MSSA Research W

  2026-06-11

  Methicillin sodium salt empowers researchers to model and interrogate Staphylococcus aureus infection dynamics with unparalleled reproducibility. This article delivers advanced workflow strategies, troubleshooting expertise, and comparative insights to optimize MSSA-focused studies using APExBIO’s validated reagent.

• (S)-(+)-Ibuprofen: Precise COX Inhibition for Translational

  2026-06-10

  This article provides deep mechanistic insight into (S)-(+)-Ibuprofen—its role as a selective COX inhibitor, its translational research applications, and strategic guidance for leveraging this molecule in advanced inflammation and pain research. Integrating recent synthetic advances, rigorous protocol parameters, and competitive perspectives, it empowers translational scientists to drive next-generation nonsteroidal anti-inflammatory drug research with confidence and reproducibility.

448 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page